Prospective Study of Cytomegalovirus Serostatus and Prostate Cancer Risk in the Prostate Cancer Prevention Trial

Cancer Causes and Control - Netherlands
doi 10.1007/s10552-012-0028-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Human Papillomavirus Types 16, 18, and 31 Serostatus and Prostate Cancer Risk in the Prostate Cancer Prevention Trial

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2010English

Serum Oxidized Protein and Prostate Cancer Risk Within the Prostate Cancer Prevention Trial

Cancer Prevention Research
MedicineCancer ResearchOncology
2010English

A Prospective Study of Socioeconomic Status, Prostate Cancer Screening and Incidence Among Men at High Risk for Prostate Cancer

Cancer Causes and Control
Cancer ResearchOncology
2012English

Prospective Multi-Institutional Study Evaluating the Performance of Prostate Cancer Risk Calculators

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Adding Genetic Risk Score to Family History Identifies Twice as Many High-Risk Men for Prostate Cancer: Results From the Prostate Cancer Prevention Trial

Prostate
OncologyUrology
2016English

Plasma Levels of Nitrate and Risk of Prostate Cancer: A Prospective Study--Letter

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2013English

Adherence to Dietary and Lifestyle Recommendations and Prostate Cancer Risk in the Prostate Testing for Cancer and Treatment (ProtecT) Trial

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2014English

Gamma-Glutamyltransferase and Risk of Prostate Cancer: Findings From the KIHD Prospective Cohort Study

International Journal of Cancer
Cancer ResearchOncology
2016English

A Prospective Study of Polyunsaturated Fatty Acid Levels in Blood and Prostate Cancer Risk

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy